|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 650.00 INR | +13.71% |
|
+39.62% | +46.60% |
| 05-23 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 40.25B 420M 369M 340M 315M 596M 608M 4.09B 1.59B 19.7B 1.58B 1.54B 68.37B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 42.35B 442M 388M 358M 331M 627M 640M 4.31B 1.67B 20.73B 1.66B 1.62B 71.95B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.71% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +19.99% | ||
| 1 week | +20.64% | ||
| Current month | +23.09% | ||
| 1 month | +60.06% | ||
| 3 months | +73.31% | ||
| 6 months | +34.71% | ||
| Current year | +29.52% |
| 1 week | 455.3 |  | 571.65 |
| 1 month | 378.85 | | 571.65 |
| Current year | 280 | | 571.65 |
| 1 year | 280 | | 656.85 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +19.99% | +20.64% | -4.58% | +49.33% | 353M | |
| -1.60% | +2.02% | +56.34% | +168.94% | 1,102B | |
| -1.44% | +3.71% | +69.07% | +65.40% | 643B | |
| -0.75% | +0.67% | +33.18% | +86.52% | 450B | |
| -1.35% | +1.86% | +29.96% | +26.28% | 336B | |
| -0.86% | +2.79% | +37.72% | +40.85% | 298B | |
| -0.71% | +0.72% | +28.85% | +48.27% | 288B | |
| -1.31% | -0.26% | -28.18% | -39.82% | 222B | |
| -0.03% | +1.84% | +23.90% | +68.30% | 199B | |
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | |
| Average | +1.15% | +2.92% | +26.86% | +59.66% | 370.63B | |
| Weighted average by Cap. | -1.16% | +2.71% | +41.37% | +86.54% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 220M 193M 179M 165M 313M 319M 2.15B 834M 10.33B 828M 810M 35.86B | 22.02B 230M 202M 186M 172M 326M 333M 2.24B 870M 10.78B 864M 845M 37.4B |
| Net income | 1.38B 14.36M 12.6M 11.63M 10.75M 20.37M 20.78M 140M 54.32M 673M 53.93M 52.75M 2.34B | 2.53B 26.41M 23.16M 21.38M 19.76M 37.45M 38.2M 257M 99.88M 1.24B 99.16M 96.99M 4.3B |
| Net Debt | 3.7B 38.66M 33.91M 31.31M 28.93M 54.83M 55.93M 376M 146M 1.81B 145M 142M 6.29B | 2.11B 22M 19.3M 17.82M 16.46M 31.21M 31.83M 214M 83.22M 1.03B 82.62M 80.81M 3.58B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | ₹650.00 | +13.71% | 585,407 |
| 08/07/26 | ₹571.65 | +19.99% | 184,079 |
| 07/07/26 | ₹476.40 | +2.66% | 24,451 |
| 06/07/26 | ₹464.05 | -1.95% | 3,294 |
| 03/07/26 | ₹473.30 | +2.14% | 5,837 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
